Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1960 1
1963 2
1964 1
1965 1
1966 5
1967 1
1968 1
1969 2
1970 2
1971 2
1972 2
1973 1
1976 2
1977 1
1978 1
1979 6
1980 3
1981 6
1982 2
1983 2
1984 5
1985 5
1986 4
1987 2
1988 4
1989 1
1990 1
1991 2
1992 2
1994 1
1996 1
1997 3
1998 1
1999 1
2000 5
2001 4
2002 8
2003 6
2004 9
2005 13
2006 14
2007 12
2008 4
2009 19
2010 29
2011 26
2012 29
2013 32
2014 35
2015 52
2016 36
2017 36
2018 27
2019 27
2020 44
2021 60
2022 56
2023 42
2024 43
2025 48
2026 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

710 results

Results by year

Filters applied: . Clear all
Page 1
Allergic Contact Dermatitis.
Kostner L, Anzengruber F, Guillod C, Recher M, Schmid-Grendelmeier P, Navarini AA. Kostner L, et al. Immunol Allergy Clin North Am. 2017 Feb;37(1):141-152. doi: 10.1016/j.iac.2016.08.014. Immunol Allergy Clin North Am. 2017. PMID: 27886903 Free article. Review.
Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.
Venditti A, Palmieri R, Maurillo L, Röllig C, Wierzbowska A, de Leeuw D, Efficace F, Curti A, Ngai LL, Tettero J, Adès L, Almeida A, Bullinger L, Dennis M, Esteve J, Ferrara F, Heuser M, Huls G, Lübbert M, Mehta P, Montesinos P, Pabst T, Récher C, Rossi G, Russell N, Sierra J, Stauder R, Vey N, Walter RB, Wang E, Nier S, Martins CG, Ossenkoppele G. Venditti A, et al. Blood Adv. 2025 May 13;9(9):2207-2220. doi: 10.1182/bloodadvances.2024013744. Blood Adv. 2025. PMID: 39913928 Free PMC article. Review.
NPM1: the ultimate target in AML.
Récher C. Récher C. Blood. 2025 Aug 28;146(9):1031-1032. doi: 10.1182/blood.2025029622. Blood. 2025. PMID: 40875551 No abstract available.
Momelotinib versus Continued Ruxolitinib or Best Available Therapy in JAK Inhibitor-Experienced Patients with Myelofibrosis and Anemia: Subgroup Analysis of SIMPLIFY-2.
Harrison CN, Vannucchi AM, Recher C, Passamonti F, Gerds AT, Hernandez-Boluda JC, Yacoub A, Sirhan S, Ellis C, Patel B, Strouse B, Platzbecker U. Harrison CN, et al. Adv Ther. 2024 Sep;41(9):3722-3735. doi: 10.1007/s12325-024-02928-4. Epub 2024 Jul 11. Adv Ther. 2024. PMID: 38990433 Free PMC article. Clinical Trial.
Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia.
Stuani L, Sabatier M, Saland E, Cognet G, Poupin N, Bosc C, Castelli FA, Gales L, Turtoi E, Montersino C, Farge T, Boet E, Broin N, Larrue C, Baran N, Cissé MY, Conti M, Loric S, Kaoma T, Hucteau A, Zavoriti A, Sahal A, Mouchel PL, Gotanègre M, Cassan C, Fernando L, Wang F, Hosseini M, Chu-Van E, Le Cam L, Carroll M, Selak MA, Vey N, Castellano R, Fenaille F, Turtoi A, Cazals G, Bories P, Gibon Y, Nicolay B, Ronseaux S, Marszalek JR, Takahashi K, DiNardo CD, Konopleva M, Pancaldi V, Collette Y, Bellvert F, Jourdan F, Linares LK, Récher C, Portais JC, Sarry JE. Stuani L, et al. J Exp Med. 2021 May 3;218(5):e20200924. doi: 10.1084/jem.20200924. J Exp Med. 2021. PMID: 33760042 Free PMC article.
The impact of post-remission granulocyte colony-stimulating factor use in the phase 3 studies of venetoclax combination treatments in patients with newly diagnosed acute myeloid leukemia.
DiNardo CD, Pratz KW, Panayiotidis P, Wei X, Vorobyev V, Illés Á, Kim I, Ivanov V, Ku G, Miller CL, Zhang M, Tatsch F, Potluri J, Schmidt X, Récher C. DiNardo CD, et al. Am J Hematol. 2025 Jan;100(1):185-188. doi: 10.1002/ajh.27515. Epub 2024 Nov 1. Am J Hematol. 2025. PMID: 39487568 Free PMC article. No abstract available.
Immunologic and Genetic Contributors to CD46-Dependent Immune Dysregulation.
Meyer BJ, Kunz N, Seki S, Higgins R, Ghosh A, Hupfer R, Baldrich A, Hirsiger JR, Jauch AJ, Burgener AV, Lötscher J, Aschwanden M, Dickenmann M, Stegert M, Berger CT, Daikeler T, Heijnen I, Navarini AA, Rudin C, Yamamoto H, Kemper C, Hess C, Recher M. Meyer BJ, et al. J Clin Immunol. 2023 Nov;43(8):1840-1856. doi: 10.1007/s10875-023-01547-y. Epub 2023 Jul 21. J Clin Immunol. 2023. PMID: 37477760 Free PMC article.
[Primary and secondary immunodeficiencies].
Cantoni N, Recher M. Cantoni N, et al. Ther Umsch. 2014 Jan;71(1):31-43. doi: 10.1024/0040-5930/a000479. Ther Umsch. 2014. PMID: 24394207 Review. German.
710 results